Onychomycosis in childhood: A current perspective with emphasis on the review of treatment;Onicomicose na infância: Uma perspectiva atual com ênfase na revisão do tratamento

Anais Brasileiros de Dermatologia

Volumn 79, Issue 2, 2004, Pages 225-232

  Arenas, Roberto ^a,b,d   Ruiz Esmenjaud, Julieta ^c,d  

^a NKB Medicina Diagnóstica   (Brazil)

^b Mycology Section

^c Departamento de Dermatologia

^d Department of Dermatology ^*

Author keywords

Child; Onychomycosis

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; BIFONAZOLE; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; UREA;

ADOLESCENT; CANDIDA; CHILD; CHILDHOOD DISEASE; DERMATOPHYTE; DRUG SAFETY; FINGER NAIL; HORMONE RELEASE; HUMAN; MEDICAL LITERATURE; MICROSPORUM CANIS; ONYCHOMYCOSIS; PARENT; PREVALENCE; PUBERTY; RELATIVE; REVIEW; RISK FACTOR; SPORT; TINEA PEDIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 2442423025     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962004000200011     Document Type: Review

References (33)

1. Barth JH, Dawber RPR. Diseases of the nail in children. Pediatr Dermatol 1987;4:4275-90.
2. Charif M, Elewski BE. Prevalence of onychomycosis in the United States: results of a population based survey. J Invest Dermatol 1996;106(4):892.
3. Arenas R, Ocejo D, Onicomicosis:frecuencia actual en un departamento de dermatología de la Ciudad de Mexico. Dermatología rev Mex 1997;41(5):171-6.
4. Gupta AK, Sibbald RG, Lynde CW et al. Onychomycosis in children: prevalence and treatment strategies. J Am Acad dermatol 1997;36:395-402.
5. Mahgoub ES. Ringworm infection among Sudanese school children. Trans R Soc Trop Med Hyg 1968;62:263-8.
6. Roy K, Ghosh GR, Dutta SK. Keratophilic fungi and the prevalence of dermatomycoses in Orissa, India. Sabouraudia 1972;10:218-29.
7. Findlay GH, Vismer HF, Sophianos T. The spectrum of pediatric dermatology. Br J Dermatol 1974;91:379-8.
8. Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol 1983;1:157-64.
9. Philpot CM, Shuttleworth D. Dermatophyte onychomycosis in children. Clin Exp Dermatol 1989;14:203-5.
10. Arenas R. Las onicomicosis. Aspectos cléinico-epidemiolagicos y terapéuticos. Gac Med Mex 1990; 126:84-9.
11. Sais G, Jucglà A, Peyrí J. Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study. Br J Dermatol 1995;132:758-61.
12. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995;133:699-703.
13. Velthuis PJ, Nijenhuis M. Treatment of onychomycosis with terbinafine in patients with Down's syndrome. Br J Dermatol 1995;133:144-5.
14. Carter DM, Jegasothy BV. Alopecia areata and Down's syndrome. Arch Dermatol 1976;112:1397-9.
15. Córdova ME, Arenas R, López C et al. Síndrome de Down. Frecuencia y características de la onicomicosis de los pies. Dermatología Rev Mex 2000;44(1):5-9.
16. Smith A. Ringworm and its treatment. London, U.K. Lewis HK, 1882:64.
17. Hennequin C, Bodemer C, Teillac D, De Prost Y. Onychomycosis in Children. J Mycol Med 1996;6:186-9.
18. Becerril-Chihu G, Bazan-Mora E, Lopez-Martinez R et al. How often are dermatophyte present in apparently normal versus scaly web of children. Pediatr Dermatol 1999;16:87-9.
19. Chang P, Logemann H. Onychomycosis in children. Int J Dermatol 1994;33:550-1.
20. Zaias N, Tosti A, Rebel G et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 1996;34:302-4.
21. Gupta AK, Scher RK, De Doncker P. Current management of onychomycosis: an overview. Dermatol Clin 1997;15:121-35.
22. Goa KL, Barradell LB. Fluconazole: An update of its pharmacokinetic properties and therapeutic use in major superficial and system mycoses in immunocompromised patients. Drugs 1995;50:658-90.
23. Jones TC. Overview of the use of terbinafine (Lamisil™) in children. Br J Dermatol 1995;132:683-9.
24. Goulden V, Goodfield MJD. Treatment of childhood dermatophyte infections with oral terbinafine. Pediatr Dermatol 1995;12:53-4.
25. Gupta AK, Chang P, Del Rosso JQ et al. Onychomycosis in Children; Prevalence and management. Pediatr Dermatol 1998;15(6):464-71.
26. Doc Jae Maeng, Masataro Hiruma, Reiko Takimoto et al. Pediatric onychomycosis treated with oral antifungal drugs. Jpn J Med Mycol 1999;40:27-30.
27. Huang Po-Hon, Paller AS. Itraconazole Pulse Therapy for Dermatophyte Onychomycosis in children. Arch Pediatr Adolesc Med 2000;154:614-618.
28. Baran R, Hay R, Haneke E, Tosti A, Piraccini BM. Onychomycosis. The current approach to diagnosis and therapy. London. Martin Dunitz Pub. 1999:64.
29. Bonifaz A, Ibarra G. Onychomycosis in Children: Treatment with Bifonazole-Urea. Pediatr Dermatol 2000;17(4):310-14.
30. Suarez S. New antifungal therapy for children. In James WDCockerell J, Dzubow LM et al. Advances in Dermatology 1997;12:195-209.
31. Abdel-Rahman SM, Gotschall RR, Kauffman RE et al. Investigation of terbinafine as a CYP2D& inhibitor in vivo. Clin Pharmacol Ther 1999;65:465-472.
32. Cartledge JD, Midgley J, Youle M et al. Itraconazole cyclodextrin solution-effective treatment for HIV-related candidiasis unresponsive to other azole therapy. J Antimicrob Chemother 1994;33:1071-3.
33. Villanueva-Quintero G, Mayorga-Rodriguez J, Barba Gómez JF. Itraconazol en pulsos para tiña de la cabeza por Microsporum canis. Informe de diez casos pediátricos. Dermatología Cosmética, Médica y Qurúrgica. 2003;1(2):97-100.